Use of Artificial Intelligence in the Design of Small Peptide Antibiotics Effective against a Broad - PowerPoint PPT Presentation

1 / 24
About This Presentation
Title:

Use of Artificial Intelligence in the Design of Small Peptide Antibiotics Effective against a Broad

Description:

In 2002, 57.1 percent (an estimated 102,000 cases) of the staph bacteria found ... peptide found in nature, in this case the bovine (as in cow) neutrophil ... – PowerPoint PPT presentation

Number of Views:113
Avg rating:3.0/5.0
Slides: 25
Provided by: libr247
Category:

less

Transcript and Presenter's Notes

Title: Use of Artificial Intelligence in the Design of Small Peptide Antibiotics Effective against a Broad


1
Use of Artificial Intelligence in the Design of
Small Peptide Antibiotics Effective against a
Broad Spectrum of Highly Antibiotic-Resistant
Superbugs
Artem Cherkasov, Kai Hilpert, HĂĄvard Jenssen,
Christopher D. Fjell, Matt Waldbrook, Sarah C.
Mullaly, Rudolf Volkmer and Robert E.W. Hancock
  • ACS Chem. Biol., 2009, 4 (1), pp 6574

2
Superbugs!
3
Why study the phenomenon of antibiotic resistance?
MRSA
MRSA infected human tissue
  • Consider the following harrowing facts
  • In 2002, 57.1 percent (an estimated 102,000
    cases) of the staph bacteria found in U.S.
    hospitals were methicillin-resistant (MRSA),
    according to CDC.
  • The total cost of antimicrobial resistance to
    U.S. society is nearly 5 billion annually,
    according to the Institute of Medicine (IOM).
  • About 2 million people acquire bacterial
    infections in U.S. hospitals each year, and
    90,000 die as a result. About 70 percent of those
    infections are resistant to at least one drug,
    according to the Centers for Disease Control and
    Prevention.
  • Recent CDC data show that in 2002, nearly 33
    percent of tested samples from ICUs were
    resistant to fluoroquinolones. P. aeruginosa
    causes infections of the urinary tract, lungs,
    and wounds and other infections commonly found in
    intensive care units.

4
Antibiotic a substance that kills or inhibits
the growth of bacteria (e.g. penicillin,
erythromycin, anisomycin,etc)
Erythromycin
Penicillin
Anisomycin
5
Bacterial Antibiotic Resistance Mechanisms
  • Different types of bacteria exhibit different
    ways of resistance.
  • Some contain enzymes to change the chemical
    structure of the antibiotic.
  • Some contain enzymes capable of splitting the
    antibiotic molecule apart.
  • Some are able to flush the antibiotic out of
    the cell before it can fatally wreck the little
    creature.
  • Each of these abilities are encoded by resistance
    genes often found in bacterial plasmid.

6
  • Peptide a polymer made up of amino acid monomers
    (e.g. the 9-mer KRWWKWIRW in Hancock et al)
  • Peptides antibiotics are simply antibiotics that
    are composed either partially or wholly of amino
    acids.
  • Almost all species have evolved antimicrobial
    peptides capable of attacking microbes directly,
    or, indirectly, by bringing about an innate or
    inflammatory immune response.

Actinomycin D
Various peptide antibiotic ribbon structures
7
(No Transcript)
8
  • Scientific goal Based on a antimicrobial peptide
    found in nature, in this case the bovine (as in
    cow) neutrophil cationic peptide bactenecin
    (RLCRIVVIRVCR-NH-2), that is known to serve a
    desirable function per this study, perhaps we can
    scramble its AA sequence to determine if there
    are even better antimicrobial peptides of the
    same length.

Cattle neutrophil bactenecin
RLCRIVVIRVCR-NH2 (from left to right)
9
SPOT 1
10
SPOT 2
11
SPOT 3
12
  • Each circular region contains a synthesized
    peptide.
  • The tiny penciled-in dots are the actual specific
    peptides.
  • Each of these can be punched out and tested for
    various biological functions (e.g. antimicrobial
    activity).

13
Proof of Bac2A variant antimicrobial activity
  • Lux assay (no graphical representation depicted
    in reference 20) is accomplished by taking the
    peptides from the SPOT synthesis, punching them
    out, transferring them to microtiter plates, and
    seeing if they reduce the ability of P.
    aeruginosa to bioluminescence.
  • An active antimicrobial peptide will destroy the
    P. aeruginosa and stop its from luminescence.
  • An inactive antimicrobial peptide will not
    destroy P. aeruginosa and thus the organisms
    beautiful bioluminescent display will persist.
  • Combinations of single or multiple AA
    substitutions led to peptides with better
    antimicrobial activity than Bac2A.

14
Training Sets (A B)
  • Preferred AAs are found in the best antimicrobial
    peptides from (refs. 20, 21). They tend to be
    hydrophobic and amphiphathic AAs.
  • Using these preferred AAs from (refs. 20, 21) the
    authors design sets of 943 and 500 cellulose
    peptides (sets A and B respectively).
  • Best set A amino acid preferences were used to
    adjust the amino acid composition of set B.
  • Adjustments made to set B resulted in better
    antimicrobial activity than set A relative to
    Bac2A.
  • Amino acid composition of set B thus formed to
    the lead amino acids to be tested in silico.

Figure 1. Occurrence of amino acids in the
training and QSAR predicted data sets. The
predicted activity quartiles from the 100,000
virtual peptide library are marked as Q1-Q4.
15
The cream of the crop Set B peptides
  • Set B peptide AA preferences, representing the
    best amino acid sequences (increased Ile, Arg,
    Val, and Trp) were used for random computer
    generation of 100, 000 virtual peptides (out of
    an astounding 70 billion possible 9-mer variants.
  • No position-specific requirements and 16 out of
    20 natural AAs used in simulation.
  • 4 peptides were not used (3 residues were found
    not make for good antimicrobials in previous
    libraries and cysteine results in dimerization
    via disulphide formation.
  • QSAR solutions from sets A and B were used to
    help evaluate the effectiveness of these 100, 000
    virtual peptides.
  • QSAR?

16
What is QSAR?
  • Quantative Structure-Activity Relationships 
  • A QSAR is a mathematical association between a
    biological goings-on of a molecular system and
    its geometric and chemical characteristics.
  • QSAR attempts to find reliable relationship
    between biological activity and molecular
    properties, so that these rules can be used to
    assess the activity of new compounds.
  • Sets A and B were used to create QSAR models
    relating chemical characteristics to
    antimicrobial activity. 
  • Artificial neural network was used to relate
    chemical descriptors to antimicrobial activity
    for the 100, 000 computer generated peptides.
  • 100, 000 peptides were broken down into four
    quartiles based on activity predicted high,
    medium, low, and completely inactive. 

17
  • Chemical space is the short qualitative answer
    to the following question How many different
    types of chemical compounds are theoretically
    capable of existing?
  • Chemical space includes biopolymers, synthetic
    polymers, metallic clusters, small carbon-based
    compounds, organometallic systems, etc.
  • Not all of chemical space may be biologically
    relevant. Even so, the number of small carbon
    based molecules with a molecular weight of less
    than 500 daltons (the molecular mass of many
    compounds found in living systems) is estimated
    to be 1 x 1060!
  • The number of compounds required for synthesis in
    order to place 10 different groups in 4 positions
    of benzene ring is 104
  • In silico modeling is thus necessary to search
    through small parts of chemical space in a
    reasonable time and cost-effective manner.
  • A type of chemoinformatic computer modeling
    called QSAR is one of the methods by which a
    virtual library of compounds can be generated
    from lead compounds with certain desirable
    drug-like characteristics.
  • But first, for the purposes of this study, a lead
    antimicrobial peptide must be developed and its
    biological activity determined (set B in Hancock
    et al 2009).

18
ANN (Artificial Neural Network)
  • neural networks are attempt to make computers
    process information like human neurons.
  • The human brain is essentially a vast array of
    interconnected neurons that respond differently
    to different types of information
  • Massive interconnectivity allows for many
    parameters to be looked all at once as opposed to
    regression analysis which typically deals with a
    much smaller number of variables.
  • Authors refer to ANN using a black box
    metaphorthat is, they are not totally sure how
    the neural network is coming up with its results.
    The authors leave to a future paper an attempt to
    explain how the ANN is working its magic (Hancock
    et al, 2009 in prep.)

Artificial Neural Network
19
Figure 2. Antimicrobial activity and physical
parameters for antimicrobial peptides from
Training Sets A and B and peptides from the
100,000 peptide virtual library.
20
Tests of Candidate Peptide Antibiotic
Effectiveness
Figure 3 Ability of the Peptides HHC-10 and
HHC-36 to protect mice against invasive S. Aureus
infection
21
Methodological Overview
22
Future directions and outstanding issues
  • Not just theory peptide antibiotic MX-226 has
    been shown to significantly limit catheter
    colonization in phase IIIa clinical trials.
  • QSAR/ANN is not a one cycle process. It exhibits
    positive feedback lead compound to improved
    virtual compound to drug candidate which may then
    be used in turn as a lead compound, ad infinitum.
  • Peptide antibiotics have some negative
    characteristics such as unknown toxicities,
    degradation by proteases (enzymes that break down
    proteins), and high cost (amino acids are
    expensive building blocks).
  • Not all of the structural characteristics of what
    makes a good peptide antibiotic are known at this
    time.

23
If all else fails.
24
Acknowledgements
  • Dr. Case
  • The students of Chem258
  • Antibiotics and bacteria
Write a Comment
User Comments (0)
About PowerShow.com